(Abst.) Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive MS patients on: July 25, 2022, 09:25:34 pm #1 From Multiple Sclerosis Journal (September 1, 2022)--"Efficacy and safety of ofatumumab in recently diagnosed ... patients with multiple sclerosis: Results from ASCLEPIOS I and II":https://journals.sagepub.com/doi/full/10.1177/13524585221078825 Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
